跳至主要内容
临床试验/CTRI/2020/06/025806
CTRI/2020/06/025806尚未招募Unknown

COMPARISION OF EFFECTIVENESS BETWEEN TAMSULOSIN AND ALFUZOSIN IN THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS IN A CASE OF BENIGN PROSTATE HYPERTROPHY: A RANDOMISED CONTROL TRIAL

ARMED FORCES MEDICAL COLLEGE1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年1月7日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
100
试验地点
1
主要终点
To study improvement in International Prostate symptom score (IPSS)

研究概览

简要总结

To compare the efficacy of Tamsulosin and Alfuzosin in the treatment of Lower Urinary tract symptoms in a case of Benign Prostate Hypertrophy in a tertiary care centre, all male patients of BPH between the ages of 40 to 80 years are evaluated by taking detailed history, clinical examination, USG KUBP & IPSS scrore. Patients would be randomised into two groups by a computer generated random table. Patients in one group would be given Tab Tamsulosin and other group would be given Tab Alfuzosin. Patients would be reviewed after 06 months and IPSS would be retaken. Pre and post treatment scores would be compared within the group and post treatment groups would be compared between the groups.

研究设计

研究类型
Interventional
分配方式
Permuted block randomization, fixed
盲法
Participant Blinded

入排标准

年龄范围
40.00 Year(s) 至 80.00 Year(s)(—)
性别
Male

入选标准

  • presenting with lower urinary tract symptoms.

排除标准

  • Past history of Prostate surgery, urethral stricture, bladder neck stenosis, vesical calculus, urethral or bladder diverticulum, neurogenic bladder, prostate or bladder cancer.

结局指标

主要结局

To study improvement in International Prostate symptom score (IPSS)

时间窗: 24 months

次要结局

  • To compare the efficacy of each drug individually(24 months)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验